Patients displaying a combined overexpression of FGFR3 and Ki67 showed an approximately four-fold higher risk for tumor progression (multivariate hazard ratio (HR): 3.943, 95% CI: 1.247 to 12.466, p = 0.019) (Table 3). Here, FGFR3 is linked to neoplasm.